Expression of Dickkopf-related Protein 1 in Patients with Temporomandibular Osteoarthritis after Treatment with Hyaluronic Acid

Sheng-jun Jiang , Zhong-zhi Jin , You-jian Peng

Current Medical Science ›› 2020, Vol. 40 ›› Issue (3) : 574 -579.

PDF
Current Medical Science ›› 2020, Vol. 40 ›› Issue (3) : 574 -579. DOI: 10.1007/s11596-020-2215-z
Article

Expression of Dickkopf-related Protein 1 in Patients with Temporomandibular Osteoarthritis after Treatment with Hyaluronic Acid

Author information +
History +
PDF

Abstract

We previously reported that the increased expression of Dickkopf-related protein 1 (DKK1) is positively related to vascular endothelial growth factor in the synovial fluid from patients with temporomandibular joint disorders (TMDs). DKK1 is involved in angiogenic activities in the TMD synovium in vitro, but the expression of DKK1 after treatment of TMD-osteoarthritis (TMD-OA) with hyaluronic acid (HA) remains unknown. In this study, we assessed the expression of DKK1 in the synovial fluid of TMD-OA patients before and after treatment with HA via enzyme-linked immunosorbent assay. We also investigated the role of DKK1 in TMD-OA via immunohistochemical staining. The relationship between the expression of DKK1 and the clinicopathological characteristics was determined by Pearson analysis. The results showed that the expression of DKK1 was significantly decreased after treatment with HA. Correlation analyses indicated that the expression of DKK1 in the TMD-OA samples was closely correlated with mouth opening and pain. These findings suggest that DKK1 could play an important role in the pathogenesis and treatment of TMD. Reduction of the pain by HA treatment may be correlated with the decreased expression of DKK1.

Keywords

Dickkopf-related protein 1 / temporomandibular joint disorders / hyaluronic acid / synovial fluid

Cite this article

Download citation ▾
Sheng-jun Jiang, Zhong-zhi Jin, You-jian Peng. Expression of Dickkopf-related Protein 1 in Patients with Temporomandibular Osteoarthritis after Treatment with Hyaluronic Acid. Current Medical Science, 2020, 40(3): 574-579 DOI:10.1007/s11596-020-2215-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

ScrivaniSJ, KeithDA, KabanLB. Temporomandibular disorders. N Engl J Med, 2008, 359(25): 2693-2705

[2]

HamptonT. Improvements needed in management of temporomandibular joint disorders. JAMA, 2008, 299(10): 1119-1121

[3]

DonahueRP, HuJC, AthanasiouKA. Remaining Hurdles for Tissue-Engineering the Temporomandibular Joint Disc. Trends Mol Med, 2019, 25(3): 241-256

[4]

SharmaS, Wactawski-WendeJ, LaMonteMJ, et al.. Incident injury is strongly associated with subsequent incident temporomandibular disorder: results from the OPPERA study. Pain, 2019, 160(7): 1551-1561

[5]

TheologisT, EfstathopoulosN, NikolaouV, et al.. Association between serum and synovial fluid Dickkopf-1 levels with radiographic severity in primary knee osteoarthritis patients. Clin Rheumatol, 2017, 36(8): 1865-1872

[6]

FerreiraN, MastersonD, Lopes de LimaR, et al.. Efficacy of viscosupplementation with hyaluronic acid in temporomandibular disorders: A systematic review. J Craniomaxillofac Surg, 2018, 46(11): 1943-1952

[7]

GoiatoMC, da SilvaEV, de MedeirosRA, et al.. Are intra-articular injections of hyaluronic acid effective for the treatment of temporomandibular disorders? A systematic review. Int J Oral Maxillofac Surg, 2016, 45(12): 1531-1537

[8]

Liang L, Tu Y, Lu J, et al. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/beta-catenin signaling pathway. J Cell Sci, 2019, 132 (10):doi: https://doi.org/10.1242/jcs.228478

[9]

HuangX, PostJN, ZhongL, et al.. Dickkopf-related protein 1 and gremlin 1 show different response than frizzled-related protein in human synovial fluid following knee injury and in patients with osteoarthritis. Osteoarthritis Cartilage, 2018, 26(6): 834-843

[10]

JiangSJ, LiW, LiYJ, et al.. Dickkopfrelated protein 1 induces angiogenesis by upregulating vascular endothelial growth factor in the synovial fibroblasts of patients with temporomandibular joint disorders. Mol Med Rep, 2015, 12(4): 4959-4966

[11]

LiW, LongX, JiangS, et al.. Histamine and substance P in synovial fluid of patients with temporomandibular disorders. J Oral Rehabil, 2015, 42(5): 363-369

[12]

SayourEJ, McLendonP, McLendonR, et al.. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Cancer Immunol Immunother, 2015, 64(4): 419-427

[13]

DongY, WuG, ZhuT, et al.. VEGF promotes cartilage angiogenesis by phospho-ERK1/2 activation of Dll4 signaling in temporomandibular joint osteoarthritis caused by chronic sleep disturbance in Wistar rats. Oncotarget, 2017, 8(11): 17849-17861

[14]

LiuJ, DaiJ, WangY, et al.. Significance of new blood vessels in the pathogenesis of temporomandibular joint osteoarthritis. Exp Ther Med, 2017, 13(5): 2325-2331

[15]

XuL, GuoH, LiC, et al.. A time-dependent degeneration manner of condyle in rat CFA-induced inflamed TMJ. Am J Transl Res, 2016, 8(2): 556-567

[16]

LiL, WangL, SunY, et al.. Establishment and histological evaluation of a goat traumatic temporomandibular joint model. J Oral Maxillofac Surg, 2015, 73(5): 943-950

[17]

CevidanesLH, WalkerD, SchillingJ, et al.. 3D osteoarthritic changes in TMJ condylar morphology correlates with specific systemic and local biomarkers of disease. Osteoarthritis Cartilage, 2014, 22(10): 1657-1667

[18]

ZhangY, ShaoS, ZhangJ, et al.. Temporal summation and motor function modulation during repeated jaw movements in patients with temporomandibular disorder pain and healthy controls. Pain, 2017, 158(7): 1272-1279

[19]

ErnbergM. The role of molecular pain biomarkers in temporomandibular joint internal derangement. J Oral Rehabil, 2017, 44(6): 481-491

[20]

MacedoCG, JainAK, Franz-MontanM, et al.. Microneedles enhance topical delivery of 15-deoxy-Delta(12,14)-prostaglandin J2 and reduce nociception in temporomandibular joint of rats. J Control Release, 2017, 265: 22-29

[21]

ZottiF, AlbaneseM, RodellaLF, et al.. Platelet-Rich Plasma in Treatment of Temporomandibular Joint Dysfunctions: Narrative Review. Int J Mol Sci, 2019, 20(2): 277

[22]

LiH, ChenY, ChenS. Enhancement of rotator cuff tendon-bone healing using bone marrow-stimulating technique along with hyaluronic acid. J Orthop Translat, 2019, 17: 96-102

[23]

PuvianiM, CampioneE, OffidaniAM, et al.. Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face. Clin Cosmet Investig Dermatol, 2019, 12: 285-293

[24]

Gokce KutukS, GokceG, ArslanM, et al.. Clinical and Radiological Comparison of Effects of Platelet-Rich Plasma, Hyaluronic Acid, and Corticosteroid Injections on Temporomandibular Joint Osteoarthritis. J Craniofac Surg, 2019, 30(4): 1144-1148

AI Summary AI Mindmap
PDF

88

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/